Mayne Pharma Group (ASX: MYX) is an Australian-listed company in the Healthcare sector with a market capitalisation of $189.7M and the 674th-largest security on the ASX by market capitalisation. The MYX share price is $2.335, down 1.06% today and down 54.81% over the past 12 months. Shares have traded between $2.04 and $6.50 over the past 52 weeks. In its most recent reported period (ending 31 Dec 2025), Mayne Pharma Group reported revenue of $212.1M and a net loss of $14.9M.
Charts
$2.35
24H Range
$2.30
$2.35
52-Week Range
$2.04
$6.50
About Mayne Pharma Group Limited
Mayne Pharma Group Ltd. operates as a specialized pharmaceutical enterprise, dedicated to the global production and distribution of both proprietary (branded) and unbranded (generic) medicinal products. Its extensive market reach spans Australia, New Zealand, North America (the United States and Canada), Europe, and Asia. The company's business activities are organized across four distinct divisions: Metrics Contract Services, International, Branded Products, and Portfolio Products. Mayne Pharma offers innovative oral drug delivery technologies and provides comprehensive contract services, including pharmaceutical development, manufacturing, and analytical support to external clients. Furthermore, the firm specializes in the distribution of pharmaceutical products tailored for key therapeutic areas such as dermatology, women's health, and infectious diseases. Incorporated in 2005, and headquartered in Salisbury South, Australia, the company was formerly known as Halcygen Pharmaceuticals Limited before rebranding to Mayne Pharma Group Limited in November 2010.
What is the Mayne Pharma Group (ASX: MYX) share price?
The MYX share price is $2.335, down 1.06% for the day, based on the latest available ASX market data.
What is Mayne Pharma Group's market capitalisation?
Mayne Pharma Group has a market capitalisation of $189.7M, making it the 674th-largest security listed on the ASX.
Does Mayne Pharma Group pay a dividend?
MYX does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.
Is Mayne Pharma Group profitable?
In its most recent reported period (ending 31 Dec 2025), MYX reported revenue of $212.1M and a net loss of $14.9M.
How many MYX shares are on issue?
Mayne Pharma Group has approximately 81,245,828 shares on issue, based on its market capitalisation of $189.7M and current share price.
What sector is Mayne Pharma Group in?
Mayne Pharma Group is classified in the Healthcare sector, within the Drug Manufacturers - General industry on the ASX.
When did Mayne Pharma Group list on the ASX?
Mayne Pharma Group listed on the Australian Securities Exchange on 29 June 2007.
MYX is held by 3 ASX-listed funds tracked on this site. The largest allocation is in iShares S&P/ASX Small Ordinaries ETF (ASX: ISO) at 0.06% of its portfolio.
